Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients

Prevalence of Depressive Symptoms and Cognitive Impairment and Their Association With Worse Outcomes in a Cohort of Hospitalized Patients With Chronic Heart Failure

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this observational study is to learn about the prevalence of depressive symptoms and cognitive impairment and their association with worse outcomes in a cohort of hospitalized patients between the ages of 18 ang 85 years with chronic heart failure. The main question it aims to answer is: • Does the presence of depressive symptoms and cognitive impairment lead to worse outcomes in a cohort of hospitalized patients with chronic heart failure? Participants who are hospitalized due to exacerbation of chronic heart failure will answer survey questions to assess their cognitive function and depressive symptoms.

Who May Be Eligible (Plain English)

Who May Qualify: - patient hospitalized primarily for CHF exacerbation; - clinically stable, able to provide willing to sign a consent form; - do not have severe cognitive impairment that would preclude valid questionnaire administration. Who Should NOT Join This Trial: - hospitalization for acute heart failure; - total length of hospital stay \<96 hours; - absence of transthoracic echocardiography (TTE) within the last 12 months and no TTE planned; - severe visual impairment preventing completion of the visual part of the Montreal Cognitive Assessment; - refusal to participate. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * patient hospitalized primarily for CHF exacerbation; * clinically stable, able to provide informed consent; * do not have severe cognitive impairment that would preclude valid questionnaire administration. Exclusion Criteria: * hospitalization for acute heart failure; * total length of hospital stay \<96 hours; * absence of transthoracic echocardiography (TTE) within the last 12 months and no TTE planned; * severe visual impairment preventing completion of the visual part of the Montreal Cognitive Assessment; * refusal to participate.

Locations (1)

Kaunas Hospital of the Lithuanian University of Health Sciences
Kaunas, Lithuania